In the PB of AML patients, circulating T follicular regulatory cells (cTfr), defined as CD4+CXCR5+PD-1+FOXP3+, were elevated, indicating increased suppression of B cell responses (41). This evidence concerns the gene FOXP3 and acute myeloid leukemia.